New York S 5942: Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs

Status: REFERRED TO HEALTH (as of 2020-01-08)

State: New York · Session: 2019-2020 · Bill: S 5942

Sponsors: SALAZAR

View New York S 5942 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.